LeMaitre Vascular, Inc. (LMAT)
80.10
+0.14
(+0.18%)
USD |
NASDAQ |
Aug 25, 10:18
LeMaitre Vascular Profit Margin (Quarterly) : 24.22% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.22% |
| March 31, 2026 | 23.56% |
| December 31, 2025 | 24.18% |
| September 30, 2025 | 28.44% |
| June 30, 2025 | 21.45% |
| March 31, 2025 | 18.39% |
| December 31, 2024 | 20.07% |
| September 30, 2024 | 20.32% |
| June 30, 2024 | 21.18% |
| March 31, 2024 | 18.49% |
| December 31, 2023 | 17.32% |
| September 30, 2023 | 15.82% |
| June 30, 2023 | 16.16% |
| March 31, 2023 | 12.83% |
| December 31, 2022 | 13.74% |
| September 30, 2022 | 13.98% |
| June 30, 2022 | 8.35% |
| March 31, 2022 | 15.26% |
| December 31, 2021 | 15.63% |
| September 30, 2021 | 16.95% |
| June 30, 2021 | 20.41% |
| March 31, 2021 | 16.52% |
| December 31, 2020 | 18.73% |
| September 30, 2020 | 20.63% |
| June 30, 2020 | 14.08% |
| Date | Value |
|---|---|
| March 31, 2020 | 10.39% |
| December 31, 2019 | 15.29% |
| September 30, 2019 | 17.81% |
| June 30, 2019 | 15.68% |
| March 31, 2019 | 12.34% |
| December 31, 2018 | 21.22% |
| September 30, 2018 | 17.85% |
| June 30, 2018 | 32.39% |
| March 31, 2018 | 14.82% |
| December 31, 2017 | 16.38% |
| September 30, 2017 | 20.31% |
| June 30, 2017 | 17.99% |
| March 31, 2017 | 13.34% |
| December 31, 2016 | 11.15% |
| September 30, 2016 | 13.91% |
| June 30, 2016 | 11.60% |
| March 31, 2016 | 10.69% |
| December 31, 2015 | 12.47% |
| September 30, 2015 | 11.11% |
| June 30, 2015 | 8.96% |
| March 31, 2015 | 7.30% |
| December 31, 2014 | 10.35% |
| September 30, 2014 | 5.39% |
| June 30, 2014 | 7.07% |
| March 31, 2014 | -1.25% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 16.63% |
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -13.17% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.74% |
| Return on Assets | 10.73% |
| Return on Invested Capital | 11.33% |
| Gross Profit Margin (Quarterly) | 70.12% |
| Operating Margin (Quarterly) | 28.98% |
| Return on Net Operating Assets | 27.68% |